# Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)

> **NCT01472926** · PHASE2 · COMPLETED · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 104 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Tenecteplase
- **DRUG:** alteplase

## Key facts

- **NCT ID:** NCT01472926
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-12-10
- **Final completion:** 2013-12-10
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2018-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01472926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01472926, "Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01472926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*